The coexistence of depression and cardiovascular disease (CVD) has been well established.
1 Although knowledge about the etiology, biology, and treatment of depression and CVD has increased in the past 2 decades,
2 the exact mechanisms linking these 2 illnesses have yet to be established. Research has demonstrated that depression and CVD may each precede the other, that they may develop concurrently, and that early signs of CVD may be mistaken for depressive symptoms.
2 Even in the absence of clearly delineated mechanisms for their relationship, the coexistence of depression and CVD is associated with worse CVD prognosis.
2,3 Treatment of depression in patients with CVD has not been demonstrated to reduce subsequent clinical events (eg, the Enhancing Recovery in Coronary Heart Disease Patients [ENRICHD] trial,
4 Sertraline Antidepressant Heart Attack Randomized Trial [SADHART],
5 and Myocardial Infarction and Depression–Intervention Trial[MIND-IT]
6). However, because the treatments in these trials only partially alleviated depressive symptoms, we cannot definitively conclude that depression treatments do not improve CVD prognosis. Nevertheless, these unsuccessful studies underscore our incomplete understanding of the link between depression and CVD.
7